More than 15 FDA-approved treatments have originated from discoveries made in Scripps Research labs. These have impacted the health of millions of people around the world—from a drug that helps premature infants breathe to vaccines for COVID-19.
ABthraxTM
raxibacumab
A monoclonal antibody engineered to destroy the anthrax toxin, purchased
by the U.S. government to protect against potential bioterror attack.
COVID-19 vaccines
Developed in record time using key innovations from Scripps Research, these vaccines help protect people from SARS-CoV-2, the coronavirus that causes COVID-19.
Zeposia®
ozanimod
A once-daily oral medicine for patients with relapsing forms of multiple sclerosis.
Trodelvy®
sacituzumab govitecan-hziy
Scientists used “click chemistry” to create this novel treatment for bladder cancer, urinary tract cancers and triple-negative breast cancer.
Vyndaqel®
tafamidis meglumine
Vyndamax®
tafamidis
Both medicines treat a debilitating, often fatal heart disease caused by protein buildup.
Mavenclad®
cladribine, oral
The first short-course oral medicine for patients with relapsing forms of multiple sclerosis.
Takhzyro®
lenadelumab-flo
Helps prevent attacks of hereditary angioedema, a rare disorder that disrupts the normal flow of blood and other fluids in the body.
Palynziq®
pegvaliase-pqpz
A novel enzyme therapy for adults with phenylketonuria (PKU), a rare and serious
genetic disease.
Bavencio®
avelumab
The first treatment for patients with metastatic Merkel cell carcinoma, now used to confront other carcinomas as well.
Unituxin®
dinutuximab
In combination with chemotherapy, treats pediatric patients with neuroblastoma, a rare brain cancer.
Portrazza®
necitumumab
Treats metastatic squamous non-small cell lung cancer, used in combination with existing chemotherapies.
Cyramza®
ramucirumab
Treats advanced gastric cancer, liver cancer and metastatic, non-small cell lung cancer.
Surfaxin®
lucinactant
Prevents respiratory distress syndrome in premature infants and injured adults.
Benlysta®
belimumab
Debuted in 2011 as the first new lupus therapy in 50 years.
Humira®
adalimumab
Prescribed worldwide to treat arthritis and other autoimmune conditions.
Leustatin®
cladribine, IV
Cures or offers a lifetime of remission for patients with hairy cell leukemia.
